Mike Doustdar, Chief Executive Officer of Novo Nordisk, claims the pharmaceutical business’s assumptions for 2026 stand for the business’s most practical analysis of advancements for the year.
发布者:BY Christopher Karlsson,转转请注明出处:https://robotalks.cn/doustdar-on-poor-2026-outlook-we-dont-want-to-disappoint-ourselves-or-the-market/